Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health syste...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a87f41a7440407eb727116a439f19d3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3a87f41a7440407eb727116a439f19d3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3a87f41a7440407eb727116a439f19d32021-12-05T18:44:06ZAntiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling10.24926/iip.v12i4.43282155-0417https://doaj.org/article/3a87f41a7440407eb727116a439f19d32021-10-01T00:00:00Zhttps://pubs.lib.umn.edu/index.php/innovations/article/view/4328https://doaj.org/toc/2155-0417 Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health systems, and rising costs of healthcare delivery with concomitant rising inequity with regards to access to health services amid the COVID-19 pandemic. The pandemic itself has stimulated an increased use of phytotherapy in Africa as a result of essential drug shortages that have been attributed to a plethora of contributing factors such as travel restrictions, reduced per capita income as well as increased expenditure on transport. As a result, the paucity of antiviral along with antiretroviral drugs used to combat COVID-19 as well as several other endemic viral diseases in Africa has created a worrisome state. This article therefore discusses and aims to underscore the causes, effects, and implications of antiviral and antiretroviral shortages amid COVID-19 in Africa. Sudhan RackimuthuZohra KazmiOsman Kamal Osman ElmahiReem HunainBehram Khan GhaziZain Ali ZaidiAna Carla dos Santos CostaShoaib AhmadMohammad Yasir EssarUniversity of Minnesota Libraries PublishingarticlePharmacy and materia medicaRS1-441ENINNOVATIONS in Pharmacy, Vol 12, Iss 4 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Pharmacy and materia medica RS1-441 |
spellingShingle |
Pharmacy and materia medica RS1-441 Sudhan Rackimuthu Zohra Kazmi Osman Kamal Osman Elmahi Reem Hunain Behram Khan Ghazi Zain Ali Zaidi Ana Carla dos Santos Costa Shoaib Ahmad Mohammad Yasir Essar Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
description |
Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health systems, and rising costs of healthcare delivery with concomitant rising inequity with regards to access to health services amid the COVID-19 pandemic. The pandemic itself has stimulated an increased use of phytotherapy in Africa as a result of essential drug shortages that have been attributed to a plethora of contributing factors such as travel restrictions, reduced per capita income as well as increased expenditure on transport. As a result, the paucity of antiviral along with antiretroviral drugs used to combat COVID-19 as well as several other endemic viral diseases in Africa has created a worrisome state. This article therefore discusses and aims to underscore the causes, effects, and implications of antiviral and antiretroviral shortages amid COVID-19 in Africa.
|
format |
article |
author |
Sudhan Rackimuthu Zohra Kazmi Osman Kamal Osman Elmahi Reem Hunain Behram Khan Ghazi Zain Ali Zaidi Ana Carla dos Santos Costa Shoaib Ahmad Mohammad Yasir Essar |
author_facet |
Sudhan Rackimuthu Zohra Kazmi Osman Kamal Osman Elmahi Reem Hunain Behram Khan Ghazi Zain Ali Zaidi Ana Carla dos Santos Costa Shoaib Ahmad Mohammad Yasir Essar |
author_sort |
Sudhan Rackimuthu |
title |
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_short |
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_full |
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_fullStr |
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_full_unstemmed |
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_sort |
antiviral and antiretroviral drug shortages amidst covid-19: how africa is struggling |
publisher |
University of Minnesota Libraries Publishing |
publishDate |
2021 |
url |
https://doaj.org/article/3a87f41a7440407eb727116a439f19d3 |
work_keys_str_mv |
AT sudhanrackimuthu antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT zohrakazmi antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT osmankamalosmanelmahi antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT reemhunain antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT behramkhanghazi antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT zainalizaidi antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT anacarladossantoscosta antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT shoaibahmad antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT mohammadyasiressar antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling |
_version_ |
1718371055351889920 |